dc.contributor.author | Bor, Wilbert | |
dc.contributor.author | Gorog, Diana | |
dc.date.accessioned | 2020-07-28T00:06:50Z | |
dc.date.available | 2020-07-28T00:06:50Z | |
dc.date.issued | 2020-07-01 | |
dc.identifier.citation | Bor , W & Gorog , D 2020 , ' Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome ' , Journal of Clinical Medicine (JCM) , vol. 9 , no. 7 . https://doi.org/10.3390/jcm9072020 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.other | PURE: 22193268 | |
dc.identifier.other | PURE UUID: 3e5a848b-d4e4-4ed3-b1a7-df752fc146f8 | |
dc.identifier.other | Scopus: 85114271966 | |
dc.identifier.uri | http://hdl.handle.net/2299/23012 | |
dc.description | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | |
dc.description.abstract | Abstract: Acute coronary syndrome and atrial fibrillation are both common, and can occur in the same patient. Combination therapy with dual antiplatelet therapy and oral anticoagulation increases risk of bleeding. Where the two conditions co-exist, careful consideration is needed to determine the optimal antithrombotic treatment to reduce the risks of future ischaemic events associated with both conditions. Choices can be made in intraprocedural anticoagulation, type and dosing of oral anticoagulant, duration of combination therapy, and selection of P2Y12 inhibitor including genetic testing. This review article provides an overview of the available evidence to support clinicians in finding the delicate balance between antithrombotic efficacy and bleeding risk in patients with acute coronary syndrome and atrial fibrillation. | en |
dc.format.extent | 14 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Clinical Medicine (JCM) | |
dc.title | Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome | en |
dc.contributor.institution | Department of Clinical and Pharmaceutical Sciences | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | Basic and Clinical Science Unit | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.description.status | Peer reviewed | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | https://doi.org/10.3390/jcm9072020 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |